Jake has over a decade of healthcare experience in managed care pricing, financial reporting, strategic analysis, regulatory analysis, and compliance. His areas of expertise include Medicare Part D, prescription drug analytics, and pharmaceutical manufacturer market access strategy.
In the Medicare market, Jake has assisted Medicare Part D plans with bid preparation and strategic analyses. He also conducts firm-wide research in formulary analytics, PDP market dynamics, and Part D risk score analysis. He is a key contributor to Milliman's Part D research efforts.
In the pharmacy space, Jake has worked with pharmaceutical manufacturers, industry organizations, and government entities, with emphasis on the Medicare Part D benefit. His recent work includes helping clients with payment strategy, market access, and regulatory issues.
